Regarding these topics, a recent study on steatotic liver disease in Cushing syndrome reported a MASLD prevalence of 26.5% in a population of 49 patient with either ACTH‐dependent or independent Cushing syndrome. This evidence concerns the gene POMC and Cushing syndrome.